A recent study published in Current Molecular Pharmacology demonstrates that puerarin-a bioactive isoflavone derived from ...
Colorectal cancer (CRC) remains one of the most heterogeneous malignancies, with substantial variability in molecular ...
Morning Overview on MSN
An mRNA vaccine halved the odds of aggressive melanoma returning after surgery
People treated for aggressive melanoma now have a concrete reason to watch a single experimental combination closely. In a ...
Recovering analytes, including proteins, nucleic acids, bacteria or viruses from dried blood samples can be challenging, especially when existing dried blood microsampling technologies create ...
Sarepta Therapeutics, Inc. , the leader in precision genetic medicine for rare diseases, today announced that the U.S. Food ...
Recently published Huntington's Disease Market Insights report includes a comprehensive understanding of current treatment ...
Korean researchers have uncovered the assembly mechanism behind a protein that regulates gene expression, opening the door to ...
"Samsung Biologics is a contract manufacturing factory — so why does it have more than 100 researchers with master's and doctoral degrees doing biote ...
Texas, USA-based biotech Vaxxirna has announced its launch as an independent company dedicated to developing vaccines powered by its proprietary viRNA circular RNA platform. Vaxxirna was founded to ...
ASCO 2026 highlighted a shift toward precision-driven oncology R&D, where biomarkers, ctDNA, and integrated strategies guide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results